PIPELINE

Sebela Pharmaceuticals is a U.S. pharmaceutical company with a market-leading position in Gastroenterology and a focus on innovation in Women’s Health. We strive to improve patients’ lives with differentiated prescription pharmaceuticals and we continue to seek opportunities to expand our core treatment areas.

GASTROENTEROLOGY
Status
Phase 1
Phase 2
Phase 2B
Phase 3
NDA Filing
Market
NTCD-M3 (Prevention of Recurrent C. diff)
Phase 2
BLI2800 (Novel Colonoscopy Prep)
Phase 1
WOMEN'S HEALTH
Status
Phase 1
Phase 2
Phase 2B
Phase 3
NDA Filing
Market